Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-223955

CEO & President sold 3,311 shares at $18.36 ($60,790)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cox John · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-13 Sale : show line 1 in the form 10b5-1 −3,311 $18.36 $60,790 370,834 D
Open-market sales · 3,311 sh · avg $18.36 · $60,790
Loading xslF345X06/ownership.xml…